This is odd. Stock has shot up, so it's understandable if an analyst says they think it's now overvalued. But MS underwrote the recent secondary at $120. Given RARE is buyout candidate, this looks a bit suspicious.
Also, seems a bit of an overreaction to an analyst's opinion.